Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Cagrilintide for Sale > Weight Loss Cagrilintide Peptide Lyophilized Powder 5mg 10mg Slimming Peptide CAS 1415456-99-3
Weight Loss Cagrilintide Peptide Lyophilized Powder 5mg 10mg Slimming Peptide CAS 1415456-99-3 buy - large image1
Weight Loss Cagrilintide Peptide Lyophilized Powder 5mg 10mg Slimming Peptide CAS 1415456-99-3 buy - image1
Weight Loss Cagrilintide Peptide Lyophilized Powder 5mg 10mg Slimming Peptide CAS 1415456-99-3 buy - image2
Weight Loss Cagrilintide Peptide Lyophilized Powder 5mg 10mg Slimming Peptide CAS 1415456-99-3 buy - image3
Weight Loss Cagrilintide Peptide Lyophilized Powder 5mg 10mg Slimming Peptide CAS 1415456-99-3 buy - image4
Weight Loss Cagrilintide Peptide Lyophilized Powder 5mg 10mg Slimming Peptide CAS 1415456-99-3 buy - image5
Weight Loss Cagrilintide Peptide Lyophilized Powder 5mg 10mg Slimming Peptide CAS 1415456-99-3 buy - image6

Weight Loss Cagrilintide Peptide Lyophilized Powder 5mg 10mg Slimming Peptide CAS 1415456-99-3

TDS 59 Inquiries

Unit Price:

$25/MT FOB

Get Latest Price
CAS No.:

1415456-99-3

Grade:

Pharmaceutical Grade

Content:

99.999%

Port:

shanghai

Brand:

china

Packaging:

10vials/box

Price valid (until):

2026-12-31

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Retatrutide,Tirzepatide,Semaglutide,GHK-CU

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


    Sale Manager:Libby

    WhatsApp: +86-19030794251


    Cagrilintide is a novel long-acting acylated amylin analogue that acts as a non-selective amylin receptor (AMYR) and calcitonin G protein-coupled receptor (CTR) agonist. Cagrilintide results in significant weight loss and reduced food intake. Cagrilintide has potential in obesity research.
    Cagrilintide: an amylin/calcitonin receptor agonist, administered once a week, with weight loss effects, developed in combination with Sema . The Sema combination, which contains cagrilintide 2.4 mg and sema 2.4 mg, is administered once weekly and has shown potential for glucose-lowering and weight loss in a Phase 2 study.
    A new long-acting amylin agonist, cagrilintide, has shown good efficacy in the treatment of obesity, especially when combined with the highly potent GLP1 receptor agonist sema, with a weight loss potential of more than 20%.

        Cagrilintide is the first long-acting amylin analog to be studied for weight management. Professor David C W Lau and his team from the Cumming School of Medicine at the University of Calgary in Canada published an article in the top medical journal "The Lancet" A major publication reports the preliminary efficacy and safety tolerability of cagrilintide for weight management in overweight and obese people. The results show that as an auxiliary means of lifestyle intervention, weekly of cagrilintide can lead to an average weight loss of up to 11.5 kg after 26 weeks, and is safe and tolerable. It is expected to provide a new solution for weight loss treatment.

    Items Specifications
    Name Cagrilintide
    Specification 2mg 5mg 10mg 15mg 20mg 30mg 40mg 50mg 60mg 100mg x10vials /box
    Purity ≥99%
    Apperance White powder
    Function Weight loss
    MOQ 1 box


    Shop Retatrutide Weight Loss Slimming Product Peptide 10mg 20mg 30mg Vials Reta-Detailed Image 1
    Shop Retatrutide Weight Loss Slimming Product Peptide 10mg 20mg 30mg Vials Reta-Detailed Image 2
    Shop Retatrutide Weight Loss Slimming Product Peptide 10mg 20mg 30mg Vials Reta-Detailed Image 3
    Shop Retatrutide Weight Loss Slimming Product Peptide 10mg 20mg 30mg Vials Reta-Detailed Image 4


    Shop Retatrutide Weight Loss Slimming Product Peptide 10mg 20mg 30mg Vials Reta-Detailed Image 5
    Shop Retatrutide Weight Loss Slimming Product Peptide 10mg 20mg 30mg Vials Reta-Detailed Image 6
    Shop Retatrutide Weight Loss Slimming Product Peptide 10mg 20mg 30mg Vials Reta-Detailed Image 7
    Shop Retatrutide Weight Loss Slimming Product Peptide 10mg 20mg 30mg Vials Reta-Detailed Image 8


    Company Profile


    Guided by our business philosophy of “Quality First, Service Oriented”, we promote the development of biotechnology with rigorous quality and service standards. Committed to innovation and continuous improvement, we aim to support the advancement of global health.


    Our core business covers weight‑management peptides, cosmetic peptides and custom peptide synthesis. Key items include Tirzepatide, Retatrutide and related products. We operate under a complete quality management system and maintain efficient client communication, delivering stable and timely custom manufacturing services for pharmaceutical APIs. Supported by our professional sales team focusing on quality and customer experience, we have accumulated rich experience in overseas trade. We keep expanding global markets, and our products are widely exported to Europe, the Americas, Southeast Asia, the Middle East, Africa and other regions worldwide.


    With solid product performance and thoughtful customer service, we sincerely hope to build long‑term stable partnerships with global clients for win‑win cooperation and mutual development.

    Shop Retatrutide Weight Loss Slimming Product Peptide 10mg 20mg 30mg Vials Reta-Detailed Image 9t...Shop Retatrutide Weight Loss Slimming Product Peptide 10mg 20mg 30mg Vials Reta-Detailed Image 10


      Type of shipping 


    Shop Retatrutide Weight Loss Slimming Product Peptide 10mg 20mg 30mg Vials Reta-Detailed Image 11


      Payment method  


    Shop Retatrutide Weight Loss Slimming Product Peptide 10mg 20mg 30mg Vials Reta-Detailed Image 12


      Q&A 


    1.How to confirm the product quality before placing an order?
    A: We can provide you with the sample. Also, we have the inspection report issued by the authoritative third-party testing agency.

    2: What's your MOQ?
    A: It depends on different products. We accept sample orders. Also for some products, we can provide you with a sample.

    3:Do you provide after-sales service?
    A: We provide 24-hour customer service. If you encounter any product quality problems or transportation problems, please feel free to contact us.

    4:How about delivery time and method?
    A: We usually ship within 1-2 working days after payments. We can make ships by sea, air, and express. Also can make door-to-door shipping.

    5:How to solve the after-sale disputes?
    A: We accept changing or refunding services if there is any quality problem.


    ECHEMI Editorial Reference
    Cagrilintide is an amylin-analog, now being developed in combination with the GLP-1 agonist semaglutide to achieve sustained weight loss in persons with overweight and obesity. This drug is an investigational therapy that reduced body weight in a phase 2 trial when administered as monotherapy in participants without diabetes and with a BMI of at least 30 kg/m2 or at least 27 kg/m2 with hypertension or dyslipidaemia[1-2].

    Certificates
    • Weight Loss Cagrilintide Peptide Lyophilized Powder 5mg 10mg Slimming Peptide CAS 1415456-99-3 Certificates 1 TDS

    Basic Info
    Product Name:

    Cagrilintide

    Other Name:

    Cagrilintide;Cargliptin;Caglitide;Cagrilintide acetate;Cagrilintide peptide;Cagrilintide 5mg 10mg 15mg;Cagrilintide(Acetate form);Kagliptin

    CAS No.:

    1415456-99-3

    Molecular Weight:

    0

    EC Number:

    206-141-6

    Color/Form:

    White to off-white

    Research
    Class:

    Amylin receptor (AMYR) / calcitonin receptor (CTR) agonist (long-acting amylin analog)

    Status:

    Investigational — Phase 3 (REDEFINE program, CagriSema combination)

    Mechanism:

    A novel long-acting, acylated amylin (islet amyloid polypeptide, IAPP) analog consisting of 38 amino acids. Cagrilintide activates the amylin receptor (AMYR) and calcitonin receptor (CTR), reducing food intake, delaying gastric emptying, and promoting satiety. Being developed as monotherapy and in fixed-dose combination with semaglutide (CagriSema) for obesity. Administered once weekly.

    Activity note:

    Cagrilintide is a non-selective AMYR/CTR agonist. Specific EC50 values not publicly available; functional potency is comparable to native amylin at AMYR.

    Source:

    MCE: Cagrilintide (CAS 1415456-99-3); Novo Nordisk REDEFINE program.

    Clinical Development:

    NCT05249895; NCT05249882

    References
    PubChem:

    PubChem

    Disclaimer:

    Cagrilintide is NOT FDA-approved or EMA-approved. It is in Phase 3 clinical trials (REDEFINE program). This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Retatrutide,Tirzepatide,Semaglutide,GHK-CU

    Location:

    Room 1209, 12th Floor, Unit 1, Building 1, Block A, Shenglong Plaza, No.80 Weiyang Road, Weiyang District, Xi'an City, Shaanxi Province, P.R.China

    Payment Terms:

    TT against copy of documents,D/A,100% TT in advance

    Average lead Time:

    15

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    11-50

    Year of Establishment:

    2025

    Xi'an Haoming Technology Co., Ltd. Founded in 2020, we are a professional supplier of high‑quality functional peptides. Our main product range includes weight‑loss peptides, anti‑wrinkle peptides, tanning peptides and other active peptide ingredients, widely used in cosmetics, skincare and health‑care industries. Strict quality‑control standards are applied throughout raw‑material screening, production and shipment to deliver consistent and reliable product quality.

    Putting customer value first, we supply premium‑grade products with competitive pricing, flexible MOQs and on‑time delivery. Our goods are well‑sold across Europe, the UK, the USA, Canada, Australia and other regions, earning wide recognition and trust from global buyers.

    We maintain stable independent international logistics channels covering the USA, Canada, UK, Germany, Spain, Poland, the Netherlands, Russia, Kazakhstan and more. One‑stop door‑to‑door delivery with full customs‑clearance service is available to free customers from cross‑border logistics troubles.

    Upholding the business philosophy of “Survive by Quality, Develop by Reputation”, Xi'an Haoming Technology Co., Ltd. keeps tight control over raw‑material procurement and production procedures. Free samples are offered prior to formal orders. All items are manufactured efficiently under high‑safety standards. Backed by a complete after‑sales system, we deliver prompt replies and professional solutions for satisfying cooperation.

    With consistent integrity, professional technical support and efficient service, we keep providing overseas partners with stable quality, competitive rates and reliable after‑sales support. Xi'an Haoming Technology Co., Ltd. aims to be your trusted long‑term supplier for peptide raw materials.

  • Inquiry History
    59 Inquiries
    Country Product Purchase Quantity Date Posted
    United Kingdom

    Cagrilintide

    10 MG Jul 31, 2026
    France

    Cagrilintide

    10 MG May 22, 2026
    Australia

    Cagrilintide

    4 MT Mar 9, 2026
    United States

    Cagrilintide

    15 MG Feb 25, 2026
    United States

    Cagrilintide

    10 PCS Dec 27, 2025
    United States

    Cagrilintide

    2 MT Dec 21, 2025
    United States

    Cagrilintide

    100 MG Oct 28, 2025
    United States

    cagrilintide

    2 MT Aug 8, 2025
    Philippines

    Retatrutide

    5 MG Aug 5, 2025
    China

    Cagrilintide

    100 G May 6, 2025
    United States

    cagrilintide

    5 MG Feb 18, 2025
    United States

    Cagrilintide

    3 MT Feb 7, 2025
    United States

    Cagrilintide

    100  Nov 12, 2024
    United States

    Cagrillintide Lyophilized powder

    100 MG Jul 4, 2024
    United States

    Cagrillintide Lyophilized powder

    1000 MG Apr 20, 2024
    United States

    Retatrutid3

    10 MT Aug 4, 2026
    United States

    Retatrutide

    20 MT Jul 25, 2026
    United States

    Cagrilintide

    10 MG Jul 13, 2026
    Peru

    Cagrilintide 20MG vial

    10 PCS Jul 10, 2026
    New Zealand

    Cagrilintide

    10 MG May 19, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.